Harold Marcotte
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Evaluation of two IgG-scFv bispecific antibodies for neutralizing Omicron variants of SARS-CoV-2.
Journal: Journal of virological methods
Published: April 02, 2025
Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variants.
Journal: Journal of virology
Published: December 04, 2024
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 09, 2024
Neutralisation activity of mucosal IgA against XBB sublineages and BA.2.86.
Journal: The Lancet. Infectious diseases
Published: October 26, 2023
Vaccination with Helicobacter pylori attachment proteins protects against gastric cancer.
Journal: bioRxiv : the preprint server for biology
Published: July 18, 2023
Helicobacter pylori attachment-blocking antibodies protect against duodenal ulcer disease.
Journal: bioRxiv : the preprint server for biology
Published: June 09, 2023
Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1.
Journal: The Lancet regional health. Western Pacific
Published: February 08, 2023
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein.
Journal: Science immunology
Published: January 26, 2023
Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2.
Journal: bioRxiv : the preprint server for biology
Published: December 09, 2022
Mucosal IgA against SARS-CoV-2 Omicron Infection.
Journal: The New England journal of medicine
Published: November 23, 2022
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection.
Journal: Pharmaceutics
Published: November 16, 2022
Last Updated: 09/26/2026